About
Gut-brain axis focus
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Team (31)
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
971
By Phase
PHASE2: 3PHASE1: 3
By Status
COMPLETED: 5RECRUITING: 1SUSPENDED: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07116499Lead Sponsor
A Study of K-645 in the Treatment of Multiple Migraine Attacks
PHASE2Recruiting
120 participants
Started: Aug 12, 2025 · Completed: May 31, 2026
NCT06848075Lead Sponsor
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine
PHASE2Completed
431 participants
Started: Mar 5, 2025 · Completed: Aug 11, 2025
NCT06451835Collaborator
Evaluation of Response to a Course of Repetitive Transcranial Magnetic Stimulation Using Vocal Biomarkers
N/ASuspended
156 participants
Started: Jun 13, 2024 · Completed: Jun 15, 2025
NCT06305351Lead Sponsor
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes
PHASE1Completed
25 participants
Started: Dec 7, 2023 · Completed: Jun 21, 2024
NCT06019559Lead Sponsor
A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833
PHASE2Completed
155 participants
Started: Sep 15, 2023 · Completed: Feb 19, 2024
Locations (1)
Headquarters
New York, NY, United States
Map
Loading map...